1 to 10 of 22 literature results

• Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.

  BACKGROUND: Because the efficacy of carboplatin and cisplatin in the treatment of advanced non-small-cell lung cancer (NSCLC) has not been proven to b…

  Authors: Andrea Ardizzoni, Luca Boni, Marcello Tiseo, Frank V Fossella, Joan H Schiller, Marianne Paesmans, Davorin Radosavljevic, Adriano Paccagnella, Petr Zatloukal, Paola Mazzanti,…

  Source: Journal of the National Cancer Institute. 2007 Jun 6

  View Full Text

• Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.

  BACKGROUND: The authors assessed the predictive and prognostic role of decline in the serum levels of carcinoembryonic antigen (CEA) and cytokeratin 1…

  Authors: Andrea Ardizzoni, Mara A Cafferata, Marcello Tiseo, Rosangela Filiberti, Paola Marroni, Francesco Grossi, Michela Paganuzzi

  Source: Cancer. 2006 Dec 15

  View Full Text

• Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines.

  The epidermal growth factor receptor (EGFR) is a validated target for therapy in non-small cell lung cancer (NSCLC). Most patients, however, either do…

  Authors: Silvia La Monica, Maricla Galetti, Roberta R Alfieri, Andrea Cavazzoni, Andrea Ardizzoni, Marcello Tiseo, Marzia Capelletti, Matteo Goldoni, Sara Tagliaferri, Antonio Mutti,…

  Source: Biochemical pharmacology. 2009 Sep 1

  View Full Text

• Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.

  BACKGROUND: The predictive and prognostic role of neuron-specific enolase (NSE) in non-small cell lung cancer (NSCLC) is still under debate. PATIENTS …

  Authors: Marcello Tiseo, Andrea Ardizzoni, Mara Argenide Cafferata, Maura Loprevite, Maurizio Chiaramondia, Rosangela Filiberti, Paola Marroni, Francesco Grossi, Michela Paganuzzi

  Source: Anticancer research. 2008 Jan-Feb

  View Full Text

• In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines.

  CI-994 (N-acetyldinaline) is a novel oral compound with a wide spectrum of antitumor activity in preclinical models, in vitro and in vivo. The mechani…

  Authors: Maura Loprevite, Marcello Tiseo, Francesco Grossi, Tindaro Scolaro, Claudia Semino, Alessandra Pandolfi, Roberto Favoni, Andrea Ardizzoni

  Source: Oncology research. 2005

  View Full Text

• Current status of second-line treatment and novel therapies for small cell lung cancer.

  Despite high response rates to first-line standard treatment, the great majority of patients with small cell lung cancer (SCLC) will relapse and succu…

  Authors: Marcello Tiseo, Andrea Ardizzoni

  Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2007 Aug

  View Full Text

• First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype.

  Lung cancer is the leading cause of cancer mortality worldwide. During the past quarter of a century, there have been definite steps forward in unders…

  Authors: Marcello Tiseo, Marco Bartolotti, Francesco Gelsomino, Andrea Ardizzoni

  Source: Expert review of anticancer therapy. 2009 Apr

  View Full Text

• Refractory pleural small cell carcinoma in never smoker. A case report.

  A 47-year-old woman who had never smoked was evaluated for chest wall pain, cough and dyspnea that proved to be due to neoplastic right pleural diseas…

  Authors: Marcello Tiseo, Elena Spiritelli, Marzia Capelletti, Guido Rindi, Andrea Ardizzoni

  Source: Tumori. 2008 May-Jun

  View Full Text

• Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).

  Neutropenia and subsequent infections are common events that limit treatment of non-small cell lung cancer (NSCLC). Granulocyte growth factors (G- and…

  Authors: Francesco Grossi, Marcello Tiseo

  Source: Critical reviews in oncology/hematology. 2006 Jun

  View Full Text

• Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report.

  Neutropenic enterocolitis, or typhlitis, is an unusual acute complication of chemotherapy-induced neutropenia, characterized by inflammatory process i…

  Authors: Marcello Tiseo, Francesco Gelsomino, Marco Bartolotti, Matteo Pesenti Barili, Andrea Ardizzoni

  Source: Lung cancer (Amsterdam, Netherlands). 2009 Aug

  View Full Text